Tell the Food and Drug Administration:
"FDA official Billy Dunn and Acting Commissioner Janet Woodcock must resign for conspiring with Big Pharma to approve Aduhelm, a dubiously ineffective new Alzheimer’s treatment!"
|
John,
The Food and Drug Administration is supposed to make sure that the medicines that doctors prescribe to Americans are safe and effective. But new reporting reveals how Big Pharma has perverted that responsibility―and how seniors will pay the price!1
StatNews just published a damning report detailing how FDA official Billy Dunn acted as a liaison for Pharma corporation Biogen throughout the approval process for Aduhelm, an Alzheimer’s treatment that many experts say may not actually work.
This is particularly brazen, because Biogen plans to charge $56,000 per year―and because the medication is marketed to seniors, Medicare will have to foot the bill. This corruption is a massive government handout to Big Pharma that provides false hope to people and families suffering from Alzheimer’s.
President Biden must clean house at the FDA and ensure that Americans can trust that our medicine is safe and effective, not create new paths to funnel Medicare money into Pharma’s pockets! Sign now!
This isn’t an isolated incident. Pharmaceutical corporations have been cozying up to FDA officials for decades, particularly during the era that Acting Commissioner Janet Woodcock has been in charge. This story only came out because Biogen’s brazen greed attracted national attention.
We need to keep up the pressure and demand that our government works for US―not greedy corporations!
Sign now to demand the resignations of Billy Dunn and Janet Woodcock for their corrupt handling of Biogen’s new Alzheimer’s drug!
Thanks,
Michael Phelan Social Security Works
1 https://www.statnews.com/2021/06/29/biogen-fda-alzheimers-drug-approval-aduhelm-project-onyx/
|